Utilization of Quantiferon-Cytomegalovirus Assay to Assess the Risk of CMV Disease and Guide Duration of Antiviral Prophylaxis in CMV-Mismatched Solid Organ Transplant Recipients | Zendy

AI Assistant Blog Pricing

Utilization of Quantiferon-Cytomegalovirus Assay to Assess the Risk of CMV Disease and Guide Duration of Antiviral Prophylaxis in CMV-Mismatched Solid Organ Transplant Recipients

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.